Likewise, data from a large, population-based case–control study (the ProtecT study) do not support the hypothesis that nonsteroidal anti-inflammatory drugs and acetaminophen play an important role in prostate cancer etiology and can influence the risk of PSA-detected prostate cancer. Here, KLK3 is linked to prostate cancer.